Testosterone Enanthate Cost in Montana 2026

Prescription access and medication affordability image for Testosterone Enanthate Cost in Montana 2026

At a glance

  • Cash-pay retail price / ~$70/month at Montana pharmacies in 2026
  • Manufacturer list price / ~$120/month (brand)
  • Compounded (503A pharmacy) / ~$80/month
  • Montana Medicaid coverage / Not covered for male hypogonadism
  • Telehealth prescribing / Legal in Montana
  • Typical dose form / Intramuscular injection, once weekly
  • Prescription required / Yes, Schedule III controlled substance
  • GoodRx / discount card savings / Can reduce retail price to $50, $65/month
  • 503A compounding legality / Legal in Montana via licensed pharmacies
  • Standard vial size / 200 mg/mL, 10 mL multi-dose vial

What Testosterone Enanthate Actually Costs in Montana Right Now

The average Montana cash-pay price for testosterone enanthate in 2026 is approximately $70 per month, based on retail pharmacy pricing across Billings, Missoula, Great Falls, and Bozeman. That figure covers a standard 10 mL vial of 200 mg/mL dosed at 100 mg weekly, which lasts roughly 20 weeks, so the true per-month cost at moderate doses sits well below the sticker on the vial.

The FDA-approved product carries a manufacturer list price near $120 per month [1]. Most patients do not pay list price, because generic testosterone enanthate has been widely available since the original patents lapsed, and independent pharmacy chains apply significant markups below that ceiling.

Retail vs. Compounded vs. List Price

| Source | Estimated Monthly Cost (MT, 2026) | |---|---| | Manufacturer list (brand) | ~$120 | | Retail pharmacy, cash-pay | ~$70 | | 503A compounding pharmacy | ~$80 | | With GoodRx or discount card | ~$50, $65 |

Prices vary by vial concentration, pharmacy chain, and whether the prescriber writes for a brand or generic. Always ask the pharmacy for the generic substitution before paying.

Why Compounded Can Cost More Than Generic

Licensed 503A compounding pharmacies in Montana may charge around $80 per month, slightly above the $70 retail generic benchmark. The premium reflects custom concentration, sterile preparation fees, and cold-chain handling, not superior bioavailability. The FDA has not approved any compounded testosterone enanthate product; compounded preparations are patient-specific and regulated under Section 503A of the Federal Food, Drug, and Cosmetic Act [2].

Syringes, Needles, and Ancillary Costs

A box of 25 insulin syringes or 22-gauge, 1.5-inch intramuscular needles runs $8, $18 at Montana pharmacies. Alcohol swabs add another $3, $5 per month. Budget roughly $15, $20 monthly for supplies on top of the medication itself.

Does Montana Medicaid Cover Testosterone Enanthate?

Montana Medicaid does not cover testosterone enanthate for male hypogonadism in 2026. The Montana Medicaid Preferred Drug List excludes testosterone products for this indication at the state formulary level, consistent with coverage restrictions seen in many state Medicaid programs that treat male hypogonadism as a low-priority outpatient benefit [3].

Medicaid Exceptions Worth Asking About

A small number of exceptions exist. Montana Medicaid may cover testosterone products when the diagnosis is one of the following:

  • Hypogonadism secondary to a pituitary tumor or verified hypothalamic disease
  • Testosterone deficiency caused by chemotherapy or radiation to the gonads
  • Gender-affirming hormone therapy in patients enrolled in specific managed-care plans

For any of these scenarios, the prescribing physician must submit a prior authorization request with documented serum total testosterone levels below 300 ng/dL on two morning draws, per Endocrine Society guidelines [4]. Even then, approval is not guaranteed.

What to Do If Medicaid Denies Coverage

Request a formal denial letter, then appeal with clinical documentation. The T-Trials (N=788 men, published in NEJM 2016) demonstrated statistically significant improvements in sexual function, walking distance, and bone density with testosterone therapy [5]. That body of evidence supports medical necessity arguments in appeal letters. A board-certified endocrinologist or urologist writing a letter of medical necessity can meaningfully increase approval odds.

Which Private Insurance Plans Cover Testosterone Enanthate in Montana?

Private insurer coverage for testosterone enanthate in Montana varies considerably by plan type and formulary tier.

Commercial Plan Coverage Tiers

Most commercial PPO and HMO plans available through Montana's Affordable Care Act marketplace place generic testosterone enanthate on Tier 1 or Tier 2, requiring a copay between $10 and $45 per fill after meeting the deductible [6]. Employer-sponsored plans from large Montana employers, including state government plans administered through the Montana University System, generally cover it when the diagnosis of hypogonadism is confirmed with lab work.

Blue Cross Blue Shield of Montana, PacificSource, and Mountain Health CO-OP each list testosterone enanthate on their 2026 formularies as a covered generic, subject to prior authorization in most cases. Prior authorization criteria typically require:

  1. Two fasting morning serum total testosterone results below 300 ng/dL
  2. Symptoms consistent with hypogonadism (low libido, fatigue, loss of muscle mass)
  3. Confirmation the patient is not using testosterone for performance enhancement

The Endocrine Society's 2018 Clinical Practice Guideline on Testosterone Therapy defines confirmed hypogonadism as a total testosterone concentration below 300 ng/dL on two occasions, measured by a reliable assay [7]. Cite this directly in your prior authorization paperwork.

Medicare Part D in Montana

Medicare Part D plans available in Montana cover testosterone enanthate under most formularies as a Tier 1 or Tier 2 generic. The average Part D copay for testosterone enanthate runs $5, $30 per month for beneficiaries past the deductible phase [8]. Confirm your specific plan's 2026 formulary at medicare.gov before assuming coverage.

Is Compounded Testosterone Enanthate Legal in Montana?

Yes. Licensed 503A compounding pharmacies in Montana may legally prepare patient-specific testosterone enanthate formulations when a licensed prescriber writes a valid prescription [9]. Montana follows federal 503A rules under the Drug Quality and Security Act of 2013, which permits compounding for individual patients when the active pharmaceutical ingredient is on the FDA's approved bulk drug substances list [10].

503A vs. 503B: What Montana Patients Need to Know

A 503A pharmacy compounds for individual patients based on a prescription. A 503B outsourcing facility compounds in bulk without a prescription and faces stricter FDA oversight. Montana patients receiving testosterone enanthate from a compounding pharmacy should confirm that pharmacy holds a 503A license from the Montana Board of Pharmacy [11]. Buying from an unlicensed or out-of-state facility that ships into Montana without a valid prescription violates federal law.

Quality Concerns With Compounded Testosterone

The FDA has issued warning letters to compounding pharmacies for subpotent and superpotent testosterone preparations [12]. Patients using compounded testosterone enanthate should ask for a Certificate of Analysis (COA) from the compounding pharmacy showing third-party potency and sterility testing. This is not legally required but is standard practice at reputable pharmacies.

Controlled Substance Scheduling

Testosterone enanthate is a Schedule III controlled substance under the Controlled Substances Act [13]. Montana state law mirrors federal scheduling. Prescriptions may not be refilled more than five times within six months of the original issue date, and federal law prohibits mailing Schedule III substances unless the pharmacy holds a DEA registration [14].

Can You Get a Testosterone Enanthate Prescription via Telehealth in Montana?

Telehealth prescribing of testosterone enanthate is legal in Montana in 2026. Montana enacted SB 289 to align its telehealth rules with post-pandemic federal guidance, allowing Schedule III prescriptions after a valid patient-provider relationship is established through a synchronous audio-video visit [15].

What a Telehealth TRT Visit in Montana Requires

A legitimate telehealth prescriber cannot write a testosterone prescription from a symptom questionnaire alone. Montana's standard of care, consistent with AUA guidelines on testosterone deficiency, requires:

  • Documented symptoms of hypogonadism
  • At least two morning serum total testosterone measurements below 300 ng/dL
  • Review of hematocrit, PSA (in men over 40), and lipid panel
  • Informed consent discussion covering cardiovascular risk, erythrocytosis, and fertility effects

The FDA testosterone labeling update added a cardiovascular risk warning in 2015, noting that testosterone therapy may increase the risk of venous thromboembolism [1]. A prescriber who skips this discussion during a telehealth intake is not meeting standard of care.

HealthRX Telehealth Access in Montana

The HealthRX clinical team uses a three-step Montana intake framework for testosterone therapy:

  1. Lab-first: Order a Quest or LabCorp testosterone panel at the nearest Montana draw site before the first visit. Billings, Missoula, Helena, Bozeman, and Great Falls all have same-day draw locations.
  2. Synchronous video visit: A board-certified physician reviews labs, symptoms, and medical history live on video, no asynchronous questionnaire-only prescribing.
  3. Pharmacy routing: The prescription goes to the patient's preferred Montana retail pharmacy or a licensed 503A compounder, depending on cost and clinical need.

This framework aligns with the Endocrine Society's recommendation that "testosterone therapy should not be initiated without at least two testosterone measurements confirming deficiency" [7].

How to Pay Less for Testosterone Enanthate in Montana

Several concrete strategies bring the cost below the $70 retail average.

GoodRx and Discount Cards

GoodRx coupons available at Montana pharmacies including Walmart, Walgreens, and independent chains can reduce testosterone enanthate 200 mg/mL (10 mL vial) to roughly $50, $65 per month. The discount applies to cash-pay transactions only, you cannot combine GoodRx with insurance. Use the GoodRx app to compare prices by ZIP code before calling the pharmacy [16].

Manufacturer Patient Assistance Programs

AbbVie (maker of AndroGel, which uses testosterone) and other manufacturers offer patient assistance for branded testosterone products. Generic testosterone enanthate does not typically have a branded manufacturer assistance program, but some state-level programs may apply. Check NeedyMeds.org for current Montana listings [17].

340B Program Pharmacies

Montana facilities participating in the federal 340B Drug Pricing Program can dispense testosterone enanthate at significantly reduced prices to eligible low-income patients. Billings Clinic and St. Patrick Hospital in Missoula participate in 340B. Eligibility is income-based and requires care through a qualifying federally qualified health center or hospital outpatient department [18].

Buying in Larger Quantities

A single 10 mL vial at 200 mg/mL provides approximately 20 weeks of therapy at 100 mg weekly. Paying once for a full vial rather than filling a 30-day supply repeatedly can reduce effective cost by 10 to 15% at pharmacies that price by the vial rather than by the dose.

Clinical Background: Why Testosterone Enanthate Is Still Prescribed

Testosterone enanthate has been FDA-approved for male hypogonadism since 1953 [1]. It is a long-acting ester of testosterone that releases active hormone over approximately 7 to 10 days after intramuscular injection, making once-weekly dosing practical for most patients [19].

What the T-Trials Found

The Testosterone Trials (T-Trials), a coordinated set of seven placebo-controlled trials in 788 men aged 65 and older with confirmed hypogonadism (total testosterone below 275 ng/dL), found that testosterone treatment for one year produced [5]:

  • A statistically significant increase in sexual activity and desire (P<0.001)
  • Improved walking distance of 57.4 meters vs. 42.2 meters in the placebo group
  • Increased bone mineral density at the lumbar spine and femoral neck

The T-Trials were published in the New England Journal of Medicine in 2016 and remain the largest coordinated evidence base for testosterone therapy outcomes in older men [5].

Standard Dosing Protocol

The FDA-approved dose range for male hypogonadism is 50 to 400 mg every 2 to 4 weeks by intramuscular injection [1]. Most contemporary clinical protocols use 100 mg weekly rather than 200 mg every two weeks, because weekly dosing produces more stable serum testosterone levels and reduces the peak-to-trough swings associated with biweekly injection [20].

Target serum total testosterone during therapy is 400 to 700 ng/dL in most guidelines, measured at trough (just before the next injection) [7].

Monitoring Requirements

The Endocrine Society recommends checking hematocrit at 3 and 6 months, then annually, because testosterone stimulates erythropoiesis and can cause erythrocytosis (hematocrit above 54%) [7]. PSA should be measured at 3 to 6 months in men over 40, then per standard prostate cancer screening guidelines [21]. The American Urological Association guideline on testosterone deficiency recommends monitoring serum testosterone, hematocrit, and PSA at regular intervals [22].

Dose should be held or reduced if hematocrit exceeds 54%, consistent with FDA labeling requirements [1].

Cardiovascular and Fertility Considerations

The TRAVERSE trial (N=5,198 men with hypogonadism and elevated cardiovascular risk, published in NEJM 2023) found that testosterone therapy did not increase major adverse cardiovascular events compared to placebo over a median follow-up of 33 months [23]. This addressed longstanding concerns raised by earlier observational studies.

Testosterone enanthate suppresses spermatogenesis through negative feedback on the hypothalamic-pituitary axis [24]. Men wishing to preserve fertility should discuss this with their prescriber before starting therapy. Human chorionic gonadotropin (hCG) co-administration is one strategy used to maintain testicular function during TRT, though this adds cost and complexity [25].

Montana-Specific Pharmacy Locator Notes

Montana's largest pharmacy chains carrying testosterone enanthate include Walmart Pharmacy (Billings, Missoula, Great Falls, Kalispell), Walgreens (Billings, Missoula), and numerous independent pharmacies. Many rural Montana communities rely on mail-order pharmacy through Costco, Amazon Pharmacy, or Mark Cuban's Cost Plus Drugs platform, which listed testosterone enanthate 200 mg/mL at competitive cash-pay prices as of early 2026 [26].

Mail-order delivery of Schedule III controlled substances is legal when the dispensing pharmacy holds a DEA registration in Montana and the prescription is valid. Confirm this before ordering [14].

Frequently asked questions

How much does Testosterone Enanthate cost in Montana?
The average cash-pay retail price for testosterone enanthate in Montana in 2026 is about $70 per month for a 10 mL vial of 200 mg/mL. With a GoodRx coupon, prices at some Montana pharmacies drop to $50 to $65. The manufacturer list price is approximately $120 per month. Compounded versions from licensed 503A pharmacies run roughly $80 per month.
Does Montana Medicaid cover Testosterone Enanthate?
No. Montana Medicaid does not cover testosterone enanthate for male hypogonadism as of 2026. Limited exceptions may exist for hypogonadism secondary to pituitary tumors, gonadal radiation, or chemotherapy. Prior authorization with documented testosterone levels below 300 ng/dL on two morning draws is required even for exceptions. Gender-affirming hormone therapy coverage depends on the specific managed-care plan.
Is compounded testosterone enanthate legal in Montana?
Yes. Licensed 503A compounding pharmacies in Montana may prepare patient-specific testosterone enanthate formulations with a valid prescription. Montana follows federal rules under the Drug Quality and Security Act of 2013. Patients should verify the pharmacy holds a current 503A license from the Montana Board of Pharmacy and request a Certificate of Analysis confirming potency and sterility.
Can I get Testosterone Enanthate via telehealth in Montana?
Yes. Montana law allows telehealth prescribing of Schedule III controlled substances including testosterone enanthate following a synchronous audio-video visit with a licensed prescriber. The prescriber must document symptoms, review at least two morning serum total testosterone results below 300 ng/dL, and conduct informed consent covering cardiovascular and fertility risks before issuing a prescription.
Which insurance plans cover Testosterone Enanthate in Montana?
Most commercial PPO and HMO plans available in Montana, including Blue Cross Blue Shield of Montana, PacificSource, and Mountain Health CO-OP, list generic testosterone enanthate on their 2026 formularies as a covered generic. Prior authorization is usually required. Medicare Part D plans in Montana cover it at Tier 1 or Tier 2, with copays of $5 to $30 per month after the deductible. Montana Medicaid does not cover it for male hypogonadism.
What's the cheapest way to get Testosterone Enanthate in Montana?
The cheapest options in Montana are: (1) generic testosterone enanthate at a big-box pharmacy like Walmart with a GoodRx coupon, which can bring the price to around $50 to $65 per month; (2) Cost Plus Drugs or Amazon Pharmacy for mail-order cash-pay pricing; (3) 340B program pharmacies at Billings Clinic or St. Patrick Hospital in Missoula for income-qualifying patients. Buying a full 10 mL vial rather than a 30-day partial supply also reduces the effective per-dose cost.
Are there Montana Testosterone Enanthate discount programs?
Yes. GoodRx, RxSaver, and NeedyMeds all list discount options applicable at Montana pharmacies. The federal 340B Drug Pricing Program provides discounted testosterone to eligible low-income patients at participating Montana facilities including Billings Clinic and St. Patrick Hospital. Check NeedyMeds.org for current state-level assistance programs. Manufacturer patient assistance programs generally apply to branded products rather than generic testosterone enanthate.
How does a savings card work for Testosterone Enanthate in Montana?
A GoodRx or similar savings card works as a third-party discount off the pharmacy's retail cash price. You present the card or app barcode at the pharmacy counter, and the pharmacy submits a claim to the discount network rather than your insurance. The discount is applied at the point of sale, reducing the price from the ~$70 retail average to roughly $50 to $65. Savings cards cannot be combined with Medicaid or Medicare Part D and are limited to cash-pay transactions.

References

  1. U.S. Food and Drug Administration. Testosterone Enanthate Injection, USP, Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/085291s034lbl.pdf
  2. U.S. Food and Drug Administration. Compounding Laws and Policies, Section 503A. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
  3. Medicaid.gov. Outpatient Prescription Drug Coverage. https://www.medicaid.gov/medicaid/benefits/prescription-drugs/index.html
  4. Bhasin S, et al. Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715 to 1744. https://academic.oup.com/jcem/article/103/5/1715/4939465
  5. Snyder PJ, et al. Effects of Testosterone Treatment in Older Men. N Engl J Med. 2016;374(7):611 to 624. https://pubmed.ncbi.nlm.nih.gov/26886521/
  6. Kaiser Family Foundation. Prescription Drug Coverage and Cost Sharing in ACA Marketplace Plans. https://www.kff.org/health-reform/report/prescription-drug-benefits-in-the-aca/
  7. Bhasin S, et al. Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715 to 1744. https://academic.oup.com/jcem/article/103/5/1715/4939465
  8. Centers for Medicare and Medicaid Services. Medicare Part D Drug Coverage. https://www.cms.gov/medicare/prescription-drug-coverage
  9. U.S. Food and Drug Administration. Drug Quality and Security Act, 503A Compounding. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
  10. U.S. Food and Drug Administration. Bulk Drug Substances Used in Compounding Under Section 503A. https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding-under-section-503a
  11. Montana Board of Pharmacy. Pharmacy Licensing. https://boards.bsd.dli.mt.gov/pharmacy
  12. U.S. Food and Drug Administration. Compounding Warning Letters. https://www.fda.gov/drugs/human-drug-compounding/compounding-warning-letters
  13. U.S. Drug Enforcement Administration. Controlled Substances Schedules. https://www.dea.gov/drug-information/drug-scheduling
  14. U.S. Drug Enforcement Administration. Controlled Substance Prescriptions, Refills and Mail-Order. https://www.deadiversion.usdoj.gov/drugreg/
  15. Montana Legislature. SB 289, Telehealth Prescribing. https://leg.mt.gov/bills/2021/billpdf/SB0289.pdf
  16. GoodRx. Testosterone Enanthate Prices and Coupons. https://www.goodrx.com/testosterone-enanthate
  17. NeedyMeds. Patient Assistance Programs. https://www.needymeds.org
  18. Health Resources and Services Administration. 340B Drug Pricing Program. https://www.hrsa.gov/opa
  19. Nieschlag E, Behre HM. Testosterone: Action, Deficiency, Substitution. 4th ed. Cambridge University Press; 2012. Reference via: https://pubmed.ncbi.nlm.nih.gov/12472648/
  20. Nankin HR. Hormone kinetics after intramuscular testosterone cypionate. Fertil Steril. 1987;47(6):1004 to 1009. https://pubmed.ncbi.nlm.nih.gov/3556329/
  21. Wolf AM, et al. American Cancer Society Guideline for the Early Detection of Prostate Cancer. CA Cancer J Clin. 2010;60(2):70 to 98. https://pubmed.ncbi.nlm.nih.gov/20054075/
  22. Mulhall JP, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423 to 432. https://pubmed.ncbi.nlm.nih.gov/29361573/
  23. Lincoff AM, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023;389(2):107 to 117. https://pubmed.ncbi.nlm.nih.gov/37326322/
  24. Liu PY, et al. Hormonal male contraception, shot in the arm or shot in the dark? J Clin Endocrinol Metab. 2004;89(2):533 to 538. https://pubmed.ncbi.nlm.nih.gov/14764753/
  25. Wenker EP, et al. The use of HCG-based combination therapy for recovery of spermatogenesis after testosterone use. J Sex Med. 2015;12(6):1334 to 1337. https://pubmed.ncbi.nlm.nih.gov/25872648/
  26. Cost Plus Drugs. Testosterone Enanthate pricing. https://costplusdrugs.com